On Tuesday, August 7, executives and guests of Taro Pharmaceuticals (NYSE: TARO), a multinational, science-based pharmaceutical company, will visit the New York Stock Exchange (NYSE) to mark the company's March 22, 2012 stock listing on the NYSE.
To celebrate the occasion, CEO James H. Kedrowski, joined by the members of the company's management team, will ring The Opening BellSM.
About Taro Pharmaceuticals (NYSE: TARO)
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit Taro's website at www.taro.com. (Source: Taro Pharmaceuticals)
Taro Pharmaceuticals Visits the NYSE
Теги
Financial Regulatory StructureInvestor ConfidenceFinancial ResponsibilityTransparencyAccountabilityFair Market DealingGlobal regulationFree EnterpriseStandardized DerivativesDe-regulationRisk TakingTrustHeritageIntegrityAdvocacyTechnologyNYSENYSE EuronextNYSE MarketNYSE ComNasdaq NYSELawJusticeBusiness SchoolInnovationSolutionsNew VisionInvestments
